19 November 2017
News and Views
Links and Services
This week's issue of the New England Journal Medicine investigates treatment with monoclonal antibodies against Clostridium difficile toxins.
New therapies are needed to manage the increasing incidence, severity, and high rate of recurrenc
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors